These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 26747037)
1. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial. Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037 [TBL] [Abstract][Full Text] [Related]
2. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S; Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):75-81. PubMed ID: 15703510 [TBL] [Abstract][Full Text] [Related]
3. Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men. Yeap BB; McCaul KA; Flicker L; Hankey GJ; Almeida OP; Golledge J; Norman PE J Clin Endocrinol Metab; 2015 Mar; 100(3):1038-47. PubMed ID: 25548977 [TBL] [Abstract][Full Text] [Related]
4. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. Banks E; Joshy G; Korda RJ; Stavreski B; Soga K; Egger S; Day C; Clarke NE; Lewington S; Lopez AD BMC Med; 2019 Jul; 17(1):128. PubMed ID: 31266500 [TBL] [Abstract][Full Text] [Related]
5. Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population. Hendriks EJ; Westerink J; de Jong PA; de Borst GJ; Nathoe HM; Mali WP; van der Graaf Y; van der Schouw YT; Beulens JW; Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):412-7. PubMed ID: 26715681 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Hu G; Jousilahti P; Qiao Q; Katoh S; Tuomilehto J Diabetologia; 2005 May; 48(5):856-61. PubMed ID: 15827741 [TBL] [Abstract][Full Text] [Related]
7. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H; Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421 [TBL] [Abstract][Full Text] [Related]
8. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. van der Leeuw J; Visseren FL; Woodward M; Zoungas S; Kengne AP; van der Graaf Y; Glasziou P; Hamet P; MacMahon S; Poulter N; Grobbee DE; Chalmers J Hypertension; 2015 Jan; 65(1):115-21. PubMed ID: 25312436 [TBL] [Abstract][Full Text] [Related]
9. Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease. Urbonaviciene G; Frystyk J; Flyvbjerg A; Henneberg EW; Lindholt JS Atherosclerosis; 2010 Jun; 210(2):619-24. PubMed ID: 20096841 [TBL] [Abstract][Full Text] [Related]
10. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Woodward M; Lam TH; Barzi F; Patel A; Gu D; Rodgers A; Suh I; Int J Epidemiol; 2005 Oct; 34(5):1036-45. PubMed ID: 15914503 [TBL] [Abstract][Full Text] [Related]
11. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. Godtfredsen NS; Osler M; Vestbo J; Andersen I; Prescott E J Epidemiol Community Health; 2003 Jun; 57(6):412-6. PubMed ID: 12775785 [TBL] [Abstract][Full Text] [Related]
12. Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study). Lyngbakken MN; Skranes JB; de Lemos JA; Nygård S; Dalen H; Hveem K; Røsjø H; Omland T Circulation; 2016 Dec; 134(24):1962-1972. PubMed ID: 27815376 [TBL] [Abstract][Full Text] [Related]
13. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. Batty GD; Li Q; Czernichow S; Neal B; Zoungas S; Huxley R; Patel A; de Galan BE; Woodward M; Hamet P; Harrap SB; Poulter N; Chalmers J; J Am Coll Cardiol; 2010 Nov; 56(23):1908-13. PubMed ID: 21109113 [TBL] [Abstract][Full Text] [Related]
14. Smoking cessation and the risk of stroke in middle-aged men. Wannamethee SG; Shaper AG; Whincup PH; Walker M JAMA; 1995 Jul; 274(2):155-60. PubMed ID: 7596004 [TBL] [Abstract][Full Text] [Related]
15. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Kengne AP; Czernichow S; Huxley R; Grobbee D; Woodward M; Neal B; Zoungas S; Cooper M; Glasziou P; Hamet P; Harrap SB; Mancia G; Poulter N; Williams B; Chalmers J; Hypertension; 2009 Aug; 54(2):399-404. PubMed ID: 19470869 [TBL] [Abstract][Full Text] [Related]
17. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM; Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382 [TBL] [Abstract][Full Text] [Related]
18. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S; Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510 [TBL] [Abstract][Full Text] [Related]
19. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials. Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461 [TBL] [Abstract][Full Text] [Related]
20. The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification. Khan AA; Chung MJ; Novak E; Mori Brooks M; Brown DL Eur J Prev Cardiol; 2017 Sep; 24(14):1506-1514. PubMed ID: 28517955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]